Evidence map›Paper›PMID 32915903›Full record

ArticlePloS one2020

Generalized cure rate model for infectious diseases with possible co-infections.

Oluwafemi Samson Balogun, Xiao-Zhi Gao, Emmanuel Teju Jolayemi, Sunday Adewale Olaleye

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Oluwafemi Samson BalogunSchool of Computing, University of Eastern Finland, Kuopio, Finland.ORCID 0000-0002-8870-9692
Xiao-Zhi GaoSchool of Computing, University of Eastern Finland, Kuopio, Finland.
Emmanuel Teju JolayemiDepartment of Statistics, Faculty of Science, University of Ilorin, Ilorin, Kwara State, Nigeria.
Sunday Adewale OlaleyeDepartment of Marketing, Management and International Business, University of Oulu, Oulu, Finland.
University of Eastern Finland · FIUniversity of Ilorin · NGUniversity of Oulu · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This research mainly aims to develop a generalized cure rate model, estimate the proportion of cured patients and their survival rate, and identify the risk factors associated with infectious diseases. The generalized cure rate model is based on bounded cumulative hazard function, which is a non-mixture model, and is developed using a two-parameter Weibull distribution as the baseline distribution, to estimate the cure rate using maximum likelihood method and real data with R and STATA software. The results showed that the cure rate of tuberculosis (TB) patients was 26.3%, which was higher than that of TB patients coinfected with human immunodeficiency virus (HIV; 23.1%). The non-parametric median survival time of TB patients was 51 months, while that of TB patients co-infected with HIV was 33 months. Moreover, no risk factors were associated with TB patients co-infected with HIV, while age was a significant risk factor for TB patients among the suspected risk factors considered. Furthermore, the bounded cumulative hazard function was extended to accommodate infectious diseases with co-infections by deriving an appropriate probability density function, determining the distribution, and using real data. Governments and related health authorities are also encouraged to take appropriate actions to combat infectious diseases with possible co-infections.

Indexed as

Models, BiologicalCoinfectionCommunicable Disease ControlCommunicable DiseasesFemaleHIV InfectionsHumansKaplan-Meier EstimateLikelihood FunctionsMaleNigeriaProportional Hazards ModelsRisk FactorsStatistics, NonparametricTuberculosis, Pulmonary

Identifiers

PMID32915903
PMCPMC7485820
OpenAlexW3084654199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.